Overall rank by patents
#26,259
Across all tracked assignees
USPTO PatentsView assignee record - 10 granted patents across 6 technology areas, active 2022–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: E21B (EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS).
The verdict
Enverus holds 10 US patents across 6 technology areas, rank #26,259 of 50,000 tracked assignees.
Enverus, Inc. has been granted 10 US utility patents between 2022 and 2025, placing Enverus, Inc. at rank #26,259 across all assignees tracked by PlainPatent. This portfolio spans 6 distinct Cooperative Patent Classification (CPC) subclasses, averaging 27.2 claims per patent with primary concentration in E21B (EARTH OR ROCK DRILLING; OBTAINING OIL, GAS, WATER, SOLUBLE OR MELTABLE MATERIALS OR A SLURRY OF MINERALS FROM WELLS). As a US Corporation, Enverus, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Enverus sits between Enpirion, Inc. (10 patents, rank #26,255) and Ernst & Young U.s. LLP (10 patents, rank #26,263) - the closest US assignees by grant volume. The composite Innovation Score of 51.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Historical data spans 2022 through 2025, with 10 total grants over that period. Velocity comparisons require five years of historical filings to calibrate. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Enverus, Inc.'s 27.2 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 6 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Enverus, Inc. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Enpirion, Inc.
10 patents
Ensighten, Inc.
10 patents
EnteroMedics Inc.
10 patents
Enterprise Electronics LLC
10 patents
Environmental Management Confederation, Inc.
10 patents
Epicentre Technologies Corporation
10 patents
Ergon, Inc.
10 patents
Ernst & Young U.S. LLP
10 patents
Enverus, Inc.
10 patents
What this shows Enverus holds 10 patents at rank #26,259, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Enverus's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
52 Top 11% higher than 89% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2022–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2022 | 4 | 40.0% |
| 2023 | 4 | 40.0% |
| 2024 | 1 | 10.0% |
| 2025 | 1 | 10.0% |
Top 6 of 6 technology areas
Overall rank by patents
#26,259
Across all tracked assignees
51.9 out of 100
How to use this portfolio
Enverus's 10 grants land it in the top 11% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.